)
)
Granules India Investor Relations Material
Latest events
Q3 24/25
Granules India
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Granules India Limited
Access all reports
Granules India Limited is a pharmaceutical company engaged in the manufacturing and distribution of active pharmaceutical ingredients (APIs), pharmaceutical formulations intermediates (PFIs), and finished dosage forms (FDFs). The company serves global pharmaceutical markets, supplying essential medicines across therapeutic categories such as pain management, cardiovascular, and anti-infectives. The company operates manufacturing facilities in India and internationally. It is headquartered in Hyderabad, India, and its shares are listed on the BSE.
Key slides for Granules India Limited
Q3 24/25
Granules India Limited
Q3 24/25
Granules India Limited
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
532482
Country
🇮🇳 India